PetIQ Market Cap

PetIQ has a market cap or net worth of $464.96 million as of April 17, 2024. Its market cap has increased by 38.67% in one year.

Market Cap

464.96M

Enterprise Value

816.89M

1-Year Change

38.67%

Ranking

#2990

Market Cap Chart

Since July 21, 2017, PetIQ's market cap has decreased from $468.80M to $464.96M, a decrease of -0.82%. That is a compound annual growth rate of -0.12%.

Market Cap History

Date	Market Cap	% Change
Apr 16, 2024	476.80M	0.13%
Apr 15, 2024	476.20M	-1.69%
Apr 12, 2024	484.40M	-4.93%
Apr 11, 2024	509.50M	-2.47%
Apr 10, 2024	522.40M	-2.26%
Apr 9, 2024	534.50M	-0.37%
Apr 8, 2024	536.50M	-0.87%
Apr 5, 2024	541.20M	-0.92%
Apr 4, 2024	546.20M	-0.82%
Apr 3, 2024	550.70M	2.59%
Apr 2, 2024	536.80M	-1.36%
Apr 1, 2024	544.20M	1.15%
Mar 28, 2024	538.00M	4.81%
Mar 27, 2024	513.30M	-1.97%
Mar 26, 2024	523.60M	2.31%
Mar 25, 2024	511.80M	-0.52%
Mar 22, 2024	514.50M	-0.68%
Mar 21, 2024	518.00M	2.64%
Mar 20, 2024	504.70M	-0.36%
Mar 19, 2024	506.50M	10.59%
Mar 18, 2024	458.00M	-1.38%
Mar 15, 2024	464.40M	1.46%
Mar 14, 2024	457.70M	-6.15%
Mar 13, 2024	487.70M	-
Mar 12, 2024	487.70M	0.85%

View and export this data all the way back to 2017. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Neurogene	481.09M
Travere Therapeutics	480.94M
ProKidney	480.53M
Third Harmonic Bio	480.02M
Theravance Biopharma	477.79M
C4 Therapeutics	470.60M
Larimar Therapeutics	465.74M
Lexicon Pharmaceuticals	460.46M

Market Cap Rankings